Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

England Sees Past Price Tag To Back GSK Bubble Baby Gene Therapy

Jan 03 2018

• By Kevin Grogan

Bubbles — NICE backs GSK's bubble baby syndrome drug • Source: Shutterstock

Related Content

Walmsley Shakes Up GSK; Cuts More Than 30 Drug Development Programs

Jul 26 2017

Spark's Luxturna Approval Ushers In A New Gene Therapy Era

Dec 19 2017

Interview: Orchard's Gene Therapies Bear Fruit With $110m Financing

Dec 20 2017

GSK Bubble Baby Syndrome Gene Therapy Gets NICE Nod

Oct 22 2017

Related Companies

GSK plc

Orchard Therapeutics Limited

Additional Topics

Reimbursement Rare Diseases Commercial Cost Effectiveness BioPharmaceutical

More from Drug Pricing

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window